Latest Market Research Reports

  Structural Heart Devices Market Summary The global  structural heart devices market  size was estimated at USD 16.13 billion in 2024 and is projected to reach USD 50.99 billion by 2033, growing at a CAGR of 13.5% from 2025 to 2033. The rapid growth of the market is primarily driven by the increasing incidence of valvular heart diseases, along with the growing adoption of advanced minimally invasive procedures. Rising awareness regarding early detection and treatment of heart valve disorders, coupled with technological advancements in cardiac devices, is enhancing patient outcomes and driving the overall demand for structural heart devices worldwide. According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease stands at approximately 7,179 cases per 100,000 individuals, reflecting the significant global burden of cardiac conditions. This increasing prevalence underscores the need for timely medical in...

  Structural Heart Devices  Industry Overview The global  structural heart devices market size  was valued at  USD 6.33 billion in 2022  and is anticipated to grow at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. The high prevalence of target diseases is the key driver of the market. Almost 60 million people in the U.S. have structural defects in their hearts. This accounts for around 20-25% of the country’s adult population. This indicates the huge scope of these devices in addressing structural heart defects. Structural heart disease (SHD) treatment includes a wide category of percutaneous treatments for patients with both acquired heart disease and congenital heart disease (CHD) that pertain to functional and structural abnormalities of cardiac chambers, proximal great vessels, and heart valves. Gather more insights about the market drivers, restrains and growth of the   Structural Heart Devices Market The reimbursement scenario in...